MarketInOut Stock Screener Log In | Sign Up

Tianjin Zhongxin Pharmaceutical Group Corp Ltd

SES • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 17:04
Tianjin Zhongxin Pharmaceutical Group Corp Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeSES
Market Capitalization3,302.58 mln
Float195 mln
Earnings Date10/23/2026

EPS

0.16
Marginal

P / E

16.19
Moderately valued

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.88
Likely reliable

Relative Strength

42 / 100
Slightly lagging

Debt / Equity

0.02
Debt-free

Business Description

Founded over a century ago and headquartered in Tianjin, China, Da Ren Tang Group is one of the country's established producers of traditional Chinese medicine. The company makes and sells a wide range of remedies targeting conditions across the heart, lungs, digestive system, joints, skin, and several other areas of health. It also offers general wellness and tonic products aimed at everyday health maintenance.

Key Fundamentals

EPS0.16
P/E16.19
ROE10.80
RPS1.17
ROIC9.38
ROA7.26
Interest Cover88.66
EBITDA, mln157
EV / EBITDA25.88
EV / EBIT29.29
Revenue, mln675
EV / Revenue5.97

Quote Details

Last 2.600
Change 0.01 (0.39%)
Open 2.590
Volume 88,300
Turnover 229,580
Average Volume 188,916

Financial Ratios

Pre-Tax Profit Margin20
Leverage Ratio1.77
Current Ratio1.38
Price / Book5.33
Price / Tangible Book5.57
Price / Cash Flow35.51
Price / Free Cash Flow39.88
Debt / Equity0.02
Price / Sales6.70
PEG Ratio1.14

Financial Strength

Altman Z-Score5.57
Piotroski F-Score 5 / 9
Beneish M-Score-2.88
Price to Intrinsic Value2.46
Price to Lynch Fair Value1.49
Price to Graham Number3.05
Shiller PE Ratio30.43

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.62% 28 / 100   
1 Month 3.17% 91 / 100   
2 Months -5.45% 66 / 100   
6 Months -8.69% 53 / 100   
1 Year 35.11% 87 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog